Landgren A, Bilberg A, Eliasson B, Torres L, Dehlin M, Jacobsson L
Adv Rheumatol. 2025; 65(1):13.
PMID: 40087727
DOI: 10.1186/s42358-025-00444-9.
Gonzalez-Gay M, Ferraz-Amaro I, Castaneda S, Pinto Tasende J, Uriarte-Ecenarro M, Plaza Z
RMD Open. 2025; 11(1).
PMID: 40055002
PMC: 11891542.
DOI: 10.1136/rmdopen-2024-005352.
Annunziata G, Verde L, Zink A, Muscogiuri G, Albanesi C, Paganelli A
Curr Nutr Rep. 2025; 14(1):42.
PMID: 40048018
PMC: 11885338.
DOI: 10.1007/s13668-025-00632-5.
Haberman R, Chen K, Howe C, Um S, Felipe A, Fu B
Arthritis Res Ther. 2025; 27(1):46.
PMID: 40038720
PMC: 11877731.
DOI: 10.1186/s13075-025-03518-7.
Tivadar S, Hugo J, Fuzesiova K, Dolezal T, Turkova B, Gkalpakiotis S
Dermatol Ther (Heidelb). 2025; .
PMID: 40032792
DOI: 10.1007/s13555-025-01374-6.
Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis.
Cagnotto G, Bruschettini M, Strozyk A, Scire C, Compagno M
Cochrane Database Syst Rev. 2025; 2:CD013614.
PMID: 39945386
PMC: 11822884.
DOI: 10.1002/14651858.CD013614.pub2.
Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium.
Karmacharya P, Crofford L, Byrne D, Stephens-Shields A, Husni M, Scher J
Ann Rheum Dis. 2025; 84(2):253-261.
PMID: 39919898
PMC: 11822222.
DOI: 10.1136/ard-2024-226150.
Imaging in clinical trials for psoriatic arthritis: a scoping review.
Xiao A, Roy A, Dennett L, Yacyshyn E, Li M
Skeletal Radiol. 2025; .
PMID: 39912887
DOI: 10.1007/s00256-025-04884-8.
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries.
Ciurea A, Kissling S, Gotschi A, Ornbjerg L, Rasmussen S, Tamasi B
Arthritis Res Ther. 2025; 27(1):18.
PMID: 39891200
PMC: 11783721.
DOI: 10.1186/s13075-025-03488-w.
Severity of skin disease strongly correlates with quality of life in people with psoriatic arthritis: a systematic review.
Pitzalis C, Myall N, Dey M, Kouranloo K
Rheumatol Int. 2025; 45(2):39.
PMID: 39883198
DOI: 10.1007/s00296-025-05791-w.
Prevalence of psoriatic arthritis in Italy: insights from the multicentric MAPSI study.
Serban T, Tramontano G, Pendolino M, Roccatello D, Epis O, Iannone F
Front Med (Lausanne). 2025; 11:1484988.
PMID: 39876867
PMC: 11773365.
DOI: 10.3389/fmed.2024.1484988.
Changes in health related quality of life in mothers with inflammatory joint disease from year 2000 to 2020 - a comparative cross-sectional study.
Koksvik H, Nilssen I, Jakobsen B, Bjorngaard H, Wallenius M, Gronning K
Front Glob Womens Health. 2025; 5():1458390.
PMID: 39845311
PMC: 11751002.
DOI: 10.3389/fgwh.2024.1458390.
Biomarkers of Extracellular Matrix Fragments in Patients with Psoriasis.
Johansen M, Holm Nielsen S, Port H, Todberg T, Lovendorf M, Skov L
Int J Mol Sci. 2025; 26(1.
PMID: 39796116
PMC: 11720200.
DOI: 10.3390/ijms26010261.
Glycosylation Pattern of Serum Clusterin in Psoriatic Arthritis and Rheumatoid Arthritis-The Search for New Diagnostic Glycomarkers.
Kratz E, Kacperczyk M, Kokot I, Piwowar A, Konopska B, Sokolik R
Int J Mol Sci. 2024; 25(23).
PMID: 39684771
PMC: 11642323.
DOI: 10.3390/ijms252313060.
Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with psoriatic arthritis in remission or low disease activity.
Ramsay H, Johnston R, Cyril S, Glennon V, Grobler L, Burgess D
Cochrane Database Syst Rev. 2024; 12():CD015880.
PMID: 39679815
PMC: 11648595.
DOI: 10.1002/14651858.CD015880.
Evaluation of the "Multivariable Psoriatic Arthritis Risk Estimation Tool" in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study.
Lubrano E, Mandato F, Antenucci M, Perrotta F
Rheumatol Ther. 2024; 12(1):203-209.
PMID: 39638968
PMC: 11751210.
DOI: 10.1007/s40744-024-00729-3.
Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors.
Mease P, Ferrante S, Shiff N, Fitzgerald T, Chakravarty S, Walsh J
Adv Ther. 2024; 42(2):734-751.
PMID: 39621228
PMC: 11787232.
DOI: 10.1007/s12325-024-03042-1.
Recent advances in nuclear medicine and their role in inflammatory arthritis: focus on the emerging role of FAPI PET/CT.
Schmidkonz C, Kuwert T, Gotz T, Ramming A, Atzinger A
Skeletal Radiol. 2024; .
PMID: 39586916
DOI: 10.1007/s00256-024-04834-w.
Association between patient's psychological health and discordance in patient-physician assessment of psoriatic arthritis.
Tan M, Xie X, Hu J, Li X, Hu K, Yang J
Clin Rheumatol. 2024; 44(1):291-297.
PMID: 39585571
DOI: 10.1007/s10067-024-07202-0.
Role of Total Body PET/CT in Inflammatory Disorders.
Zoghi S, Mingels C, Badawi R, Spencer B, Yarbrough T, Nardo L
Semin Nucl Med. 2024; 55(1):41-51.
PMID: 39578110
PMC: 11645246.
DOI: 10.1053/j.semnuclmed.2024.11.001.
